Synapse

← Atherosclerosis Plus

Papers in Atherosclerosis Plus

Page 1 · newest first

  1. PCSK9 inhibitors and atherosclerotic plaque regression and stabilisation across major arterial beds: a systematic review with narrative synthesisAtherosclerosis Plus · 2026
  2. Simulation of low-density lipoprotein cholesterol goal attainment with treatment intensification in a population with homozygous familial hypercholesterolemiaAtherosclerosis Plus · 2026
  3. Aortic Plaque Morphology and Cholesterol Crystal Release Assessed Using Non-Obstructive General AngioscopyAtherosclerosis Plus · 2026
  4. Long-term real-world efficacy of inclisiran at 15 months: new results from the INCLIVEN multicenter registryAtherosclerosis Plus · 2026
  5. Sex-related patterns of LDL-C/small dense LDL-C discordance among Japanese adults with non-elevated LDL-CAtherosclerosis Plus · 2026
  6. Choline fenofibrate add-on to statins in persistent hypertriglyceridemia: efficacy, apoB-containing lipoprotein remodeling, and renal functionAtherosclerosis Plus · 2026
  7. Arginine and homoarginine as predictors of cardiovascular mortality in chronic coronary syndromeAtherosclerosis Plus · 2026
  8. Apolipoprotein C-III inhibitors reduce triglycerides and acute pancreatitis risk: a systematic review and meta-analysisAtherosclerosis Plus · 2026
  9. Global Genetic Architecture of Familial Chylomicronaemia Syndrome: Insights from the FCS International Collaboration Project (FCS IP).Atherosclerosis Plus · 2026
  10. The value and limitations of genetic testing in diagnosing and advising on cardiovascular risk in the rare Tangier DiseaseAtherosclerosis Plus · 2026
  11. How calculated LDL-cholesterol compares with direct measurement: performance and cost analysis from a large NHS service evaluationAtherosclerosis Plus · 2026
  12. TUDOR: a treatment-adjusted diagnostic algorithm for familial hypercholesterolaemia with dual external validation in 4,028 genetically confirmed casesAtherosclerosis Plus · 2026
  13. Lipoprotein (a) testing- insights from the laboratoryAtherosclerosis Plus · 2026
  14. Clonal Hematopoiesis is Associated with Adverse Events in Patients with High-Grade Carotid Artery StenosisAtherosclerosis Plus · 2026
  15. Lipoprotein(a) and early LDL-cholesterol target attainment after a first acute coronary syndrome: a real-world cohort studyAtherosclerosis Plus · 2026
  16. Very low HDL cholesterol in infectious mononucleosis with hepatitis: a real-world evidence studyAtherosclerosis Plus · 2026
  17. Plasma untargeted metabolomics in coronary artery disease – Correlation with degree of obstructionAtherosclerosis Plus · 2026
  18. Association between serum lipoprotein(a) levels and aortic vulnerable plaques assessed by non-obstructive general angioscopyAtherosclerosis Plus · 2026
  19. Orthopedic Surgery changes Aortic Valve Composition in ApoE-/- mice.Atherosclerosis Plus · 2026
  20. Putative protective role of PCSK9 variants in a multigenerational family with familial hypercholesterolemiaAtherosclerosis Plus · 2026
  21. Association of Lipoprotein(a) with the Angiographic Extent of Coronary Artery Disease and Selected Angiographic Findings in Patients with Acute Coronary Syndromes.Atherosclerosis Plus · 2026
  22. Associations Between Carotid Macrovascular and Retinal Microvascular Alterations in Diabetes: Evidence Synthesis and Implications for Risk AssessmentAtherosclerosis Plus · 2026
  23. The association between albuminuria and coronary atherosclerotic burden in the general populationAtherosclerosis Plus · 2026
  24. Microbial mechanisms in atherosclerosis: Revisiting the infectious hypothesisAtherosclerosis Plus · 2026
  25. Associations of long-term vitamin K antagonist and direct oral anticoagulant therapies with progression of coronary artery calcification: A Danish population-based studyAtherosclerosis Plus · 2026
  26. Cholesterol in amyotrophic lateral sclerosis: a bystander, a biomarker, or a target?Atherosclerosis Plus · 2026
  27. LDL-Cholesterol Distance to Target: A Practical Tool for Guiding Lipid-Lowering Treatment DecisionsAtherosclerosis Plus · 2026
  28. Real-world Cardiovascular Risk Estimation, Blood Pressure and LDL-Cholesterol Control: Two Epidemiological Studies in Romania, during pandemic and post-pandemic (SNAPSHOT-Romania)Atherosclerosis Plus · 2026
  29. Effects of evolocumab on plasma coenzyme Q10 in patients with heterozygous familial hypercholesterolemiaAtherosclerosis Plus · 2026
  30. Awareness and perceptions of systemic inflammation in atherosclerotic cardiovascular disease and chronic kidney disease: The SPARK-CVD China surveyAtherosclerosis Plus · 2026
  31. Retinal findings in familial hypercholesterolemia: An exploratory case-control studyAtherosclerosis Plus · 2026
  32. Lipoprotein metabolism and inflammation in healthy young subjects – exploring the postprandial and postabsorptive phases following intake of a standardized mealAtherosclerosis Plus · 2026
  33. Association of the C-reactive protein-triglyceride-glucose index (CTI) with lower-extremity peripheral artery disease among U.S. adultsAtherosclerosis Plus · 2026
  34. Parallel screening strategies reveal distinct phenotypic and genotypic profiles of familial hypercholesterolemia in children and adultsAtherosclerosis Plus · 2026
  35. Expert Consensus on Lipoprotein(a) in the Gulf Countries: Navigating Cardiovascular Risk and Therapeutic AdvancesAtherosclerosis Plus · 2026
  36. Sex-Specific Associations of the Triglyceride-Glucose Index With Systemic Inflammation and Arterial Stiffness in Adults With Normal Glucose and Triglyceride LevelsAtherosclerosis Plus · 2026
  37. Associations of lipoprotein(a) concentrations with cardiovascular disease in men and women with primary hypercholesterolemiaAtherosclerosis Plus · 2026
  38. Environmental pollution, apolipoprotein A-1 autoantibodies and cardiovascular risk: evidence from a geospatial cross-sectional studyAtherosclerosis Plus · 2026
  39. CNN3 promotes vascular smooth muscle cells proliferation and migration to deteriorate atherosclerosis by β-catenin signaling pathwayAtherosclerosis Plus · 2026
  40. Plasma-derived small extracellular vesicle miR-660-5p as a predictor for carotid plaque vulnerability and postoperative major adverse cardiovascular event riskAtherosclerosis Plus · 2026
  41. Systematic literature review on the real-world effectiveness and safety of bempedoic acidAtherosclerosis Plus · 2026
  42. Proprotein convertase subtilisin/kexin type 9–CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery diseaseAtherosclerosis Plus · 2026
  43. Calciprotein particles disrupt autophagy in vascular endothelial cells and smooth muscle cellsAtherosclerosis Plus · 2026
  44. Association between HIV Infection and Arterial Stiffness: A Population-Based Cross-Sectional Study from Rakai, South Western Uganda.Atherosclerosis Plus · 2026
  45. PCSK9 in vascular smooth muscle cells: biology, pathology, and inhibition to fight atherosclerosisAtherosclerosis Plus · 2026
  46. Associations of NMR Metabolic Biomarkers and Arterial Calcification: an Observational and Mendelian Randomization Study within the BBMRI Metabolomics ConsortiumAtherosclerosis Plus · 2026
  47. Is there a link between non-steroidal anti-inflammatory drugs and cardiovascular risk in patients with inflammatory arthritis?Atherosclerosis Plus · 2026
  48. Population-based reference intervals for lipid function tests in pregnant and non-pregnant women in Nairobi City, KenyaAtherosclerosis Plus · 2026
  49. Role of Abnormal Phosphatidylcholine Metabolism in Endoplasmic Reticulum Stress-Induced Carotid Artery Plaque DestabilizationAtherosclerosis Plus · 2026
  50. Role and mechanism of G9A-BMP2 in calcification-induced formation of unstable plaqueAtherosclerosis Plus · 2026